Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/20028874

Cancer Res. 2010 Jan 1 70 1 299-308

Download in:

View as

Triples

General Info

PMID
20028874